-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Applied Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2024.
- Applied Therapeutics, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$33M, a 57.2% decline year-over-year.
- Applied Therapeutics, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$104M, a 61.6% decline year-over-year.
- Applied Therapeutics, Inc. annual Operating Income (Loss) for 2024 was -$104M, a 61.6% decline from 2023.
- Applied Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$64.5M, a 22.2% increase from 2022.
- Applied Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$83M, a 21.5% increase from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)